ClinicalTrials.Veeva

Menu

Different Modalities for the Evaluation of Patients With Peri-menopausal Bleeding

S

Sohag University

Status

Enrolling

Conditions

Perimenopausal Bleeding

Treatments

Diagnostic Test: three dimensional ultrasonography
Diagnostic Test: Hysteroscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT07309692
Soh-Med-25-9----11MS

Details and patient eligibility

About

The study aims to compare between 3D ultrasonography and hysteroscopy for the evaluation of cases with Peri-menopausal bleeding

Enrollment

106 estimated patients

Sex

Female

Ages

40 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Any pattern of abnormal uterine bleeding as menorrhagia or metrorrhagia for more than 3 months at age between 40 and 55 years , and no ovarian lesion or local cause of bleeding as vaginal or cervical ulcer

Exclusion criteria

  • • Women with postmenopausal bleeding.

    • Systemic causes of perimenopausal bleeding DM Hypertension or chronic liver disease.
    • Women on hormonal therapy or using any contraception as IUD.
    • Women have contraindication for hysteroscopy as cervical stenosis or pregnancy.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

106 participants in 1 patient group

Patients with perimenopausal bleeding
Experimental group
Treatment:
Diagnostic Test: Hysteroscopy
Diagnostic Test: three dimensional ultrasonography

Trial contacts and locations

1

Loading...

Central trial contact

ahmed abdelrahem fattouh, resident of Obstetrics and Gyn

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems